Citation: L. Amaral et Je. Kristiansen, Phenothiazines: potential management of Creutzfeldt-Jacob disease and its variants, INT J ANT A, 18(5), 2001, pp. 411-417
Citation: Wl. Hand et Dl. Hand, Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes, INT J ANT A, 18(5), 2001, pp. 419-425
Citation: G. Treadway et A. Reisman, Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases, INT J ANT A, 18(5), 2001, pp. 427-431
Authors:
Schmitz, FJ
Perdikouli, M
Beeck, A
Verhoef, J
Fluit, AC
Citation: Fj. Schmitz et al., Molecular surveillance of macrolide, tetracycline and quinolone resistancemechanisms in 1191 clinical European Streptococcus pneumoniae isolates, INT J ANT A, 18(5), 2001, pp. 433-436
Citation: L. Deshpande et al., Antimicrobial activity of BMS 284756 (T-3811) against Neisseria gonorrhoeae tested by three methods, INT J ANT A, 18(5), 2001, pp. 437-440
Authors:
Sambatakou, H
Giamarellos-Bourboulis, EJ
Galanakis, N
Giamarellou, H
Citation: H. Sambatakou et al., Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: the significance of penetration in the ascitic fluid, INT J ANT A, 18(5), 2001, pp. 441-444
Authors:
Tunger, O
Arisoy, A
Kurutepe, S
Akcali, S
Ozbakkaloglu, B
Citation: O. Tunger et al., In vitro susceptibility of Staphylococcus aureus and coagulase-negative Staphylococcus strains to fusidic acid, INT J ANT A, 18(5), 2001, pp. 445-447
Authors:
Mori, N
Kodama, T
Sakai, A
Suzuki, T
Sugihara, T
Yamaguchi, S
Nishijima, T
Aoki, A
Toriya, M
Kasai, M
Hatano, S
Kitagawa, M
Yoshimi, A
Nishimura, K
Citation: N. Mori et al., AS-924, a novel, orally active, bifunctional prodrug of ceftizoxime: physicochemical properties, oral absorption in animals, and antibacterial activity, INT J ANT A, 18(5), 2001, pp. 451-461
Authors:
Totsuka, K
Shimizu, K
Mori, N
Sugihara, T
Sakai, A
Yamaji, S
Michisuji, Y
Shinohara, Y
Kubo, A
Tokuoka, H
Citation: K. Totsuka et al., Effects of food intake and age on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic. Comparison with cefpodoxime proxetil, INT J ANT A, 18(5), 2001, pp. 463-469
Authors:
Matsumoto, F
Sakurai, I
Morita, M
Takahashi, T
Mori, N
Sugihara, T
Sakai, A
Yamaji, S
Akaike, Y
Yano, K
Citation: F. Matsumoto et al., Effects of the quantity of water and milk ingested concomitantly with AS-924, a novel ester-type cephem antibiotic, on its pharmacokinetics, INT J ANT A, 18(5), 2001, pp. 471-476
Authors:
Totsuka, K
Shimizu, K
Mori, N
Sugihara, T
Sakai, A
Yamaji, S
Michisuji, Y
Shinohara, Y
Kubo, A
Tokuoka, H
Citation: K. Totsuka et al., Effect of antacid pretreatment on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic - comparison with cefteram-pivoxil, INT J ANT A, 18(5), 2001, pp. 477-482
Authors:
Yanagawa, A
Shimada, J
Mori, N
Sugihara, T
Sakai, A
Yamaji, S
Yano, K
Kitamura, T
Kano, T
Citation: A. Yanagawa et al., Effects of gastrointestinal stimulant and suppressant pretreatment on the pharmacokinetics of AS-924, a novel ester-type cephem antibiotic, INT J ANT A, 18(5), 2001, pp. 483-487
Authors:
Esposito, S
Noviello, S
Ianniello, F
D'Errico, G
Citation: S. Esposito et al., Short-course therapy with cefaclor for treatment of streptococcal pharyngotonsillitis, INT J ANT A, 18(4), 2001, pp. 341-345
Authors:
Stratchounski, LS
Kretchikova, OI
Reshedko, GK
Stetsiouk, OU
Kandalov, MM
Egorova, OA
Boyko, LM
Ryabkova, EL
Tarasova, GD
Blokhin, BM
Citation: Ls. Stratchounski et al., Antimicrobial susceptibility of nasopharyngeal isolates of Haemophilus influenzae from healthy children in day-care centres: results of multicentre study in Russia, INT J ANT A, 18(4), 2001, pp. 347-351
Authors:
Saenz, Y
Zarazaga, M
Brinas, L
Lantero, M
Ruiz-Larrea, F
Torres, C
Citation: Y. Saenz et al., Antibiotic resistance in Escherichia coli isolates obtained from animals, foods and humans in Spain, INT J ANT A, 18(4), 2001, pp. 353-358
Citation: H. Niwa et al., Rapid detection of mutations associated with resistance to erythromycin inCampylobacter jejuni/coli by PCR and line probe assay, INT J ANT A, 18(4), 2001, pp. 359-364
Authors:
Zheng, XT
Johnson, C
Lu, YN
Yanagihara, R
Hollingshead, S
Crain, M
Benjamin, W
Waites, KB
Citation: Xt. Zheng et al., Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes, INT J ANT A, 18(4), 2001, pp. 373-378
Authors:
Lopez, H
Vilches, V
Scarano, S
Stepanik, D
Smayevsky, J
Lemme, L
Cardenosa, O
Ambler, J
Sucari, A
Citation: H. Lopez et al., Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens, INT J ANT A, 18(4), 2001, pp. 379-382
Authors:
Maltezou, HC
Baka, M
Gombakis, N
Koliouskas, DE
Kosmidou, H
Malaka-Zafiriou, E
Kafetzis, DA
Citation: Hc. Maltezou et al., Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies, INT J ANT A, 18(4), 2001, pp. 383-386
Authors:
Dzierzanowska-Fangrat, K
Rozynek, E
Jozwiak, P
Celinska-Cedro, D
Madalinski, K
Dzierzanowska, D
Citation: K. Dzierzanowska-fangrat et al., Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland, INT J ANT A, 18(4), 2001, pp. 387-390